1. Abeliovich, D., Kaduri, L., Lerer, I., Weinberg, N., Amir, G., Sagi, M., et al. (1997). The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60 % of ovarian cancer and 30 % of early-onset breast cancer patients among Ashkenazi women. American Journal of Human Genetics, 60, 505–514.
2. Bach, G., Zeigler, M., & Zlotogora, J. (2007). Prevention of lysosomal storage disorders in Israel. Molecular Genetics and Metabolism, 90, 353–357.
3. Balkite, E. A., & Smith, M. E. (1999). Evolving roles, expanding opportunities. In W. R. Uhlmann, J. R. Schuette, & B. M. Yashar (Eds.), A guide to genetic counseling (2nd ed., pp. 523–551). New York: Wiley-Blackwell.
4. Ben-Shachar, S., Orr-Urtreger, A., Bardugo, E., Shomrat, R., & Yaron, Y. (2011). Large-scale population screening for spinal muscular atrophy: clinical implications. Genetics in Medicine, 13, 110–114.
5. Berkenstadt, M., Ries-Levavi, L., Cuckle, H., Peleg, L., & Barkai, G. (2007). Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests. Prenatal Diagnosis, 27, 991–994.